This effect may be mediated through NF-κB, which has been shown to correlate with heparanase expression in several cancers, as the overexpression of EcSOD both in vitro and in vivo was associated with decreased NF-κB expression and nuclear localization [37,59]. This evidence concerns the gene NFKB1 and cancer.